RxDoctor Payments Data

Katherine McKenzie, DO

Surgery · Jamaica, NYNPI 1588905103

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $754 of the $1,099 with a category attached, or 68.6%. CSL Behring accounts for 83.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $915 and has fallen 91.8% since, to $75 in 2025. That places this record below the midpoint for surgery clinicians in NY, where the typical reported total is $1,254.

$1,099in general payments, 2019–2025

Across 11 payments — averaging $99.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$915
  • TELA Bio, Inc.$110
  • Polynovo North America LLC$75
$146,368in research payments, 2019–2025

Across 14 payments — averaging $10,455 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$140K
  • Seqirus USA Inc$7K

What the payments were for

  • Travel & lodging$75469%
  • Food & beverage$34631%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring9$915
TELA Bio, Inc.1$110
Polynovo North America LLC1$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,099 in reported general payments places this provider in the 45th percentile of 1,596 surgery providers in New York.

See all surgery providers in New York

Medicare billing

Part B allowed, 2024
$10,808
Medicare patients
34
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Jamaica

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →